Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Human growth hormone products recommended for approval

Dec. 16, 1996

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

Encouraging clinical results with MacroChem Rx for impotence

Dec. 13, 1996

Chugai reports new cholesterol-lowering compounds

Dec. 13, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

New hypolipidemic agents claimed by Janssen

Dec. 12, 1996

Scotia drug shows excellent activity in cancer patients with cachexia

Dec. 11, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...